Engaging patients, clinicians, and community members in the development of a research network creates opportunities and challenges beyond engagement in discrete learning activities. This paper describes our experiences establishing and The engagement of patients, clinicians, and other stakeholders throughout the research process is a defining feature of CER and PCOR. With the growing trend toward stakeholder-engaged research both in the United States and internationally, a significant body of
literature has emerged surrounding the potential of stakeholder engagement to improve the relevance and impact of clinical research.
Although evidence to support one method of engagement over another is currently lacking, [3] [4] [5] efforts to delineate the characteristics of successful engagement strategies commonly cite factors such as adequate orientation, clearly defined roles, a concerted effort to establish relationships across perceived hierarchies, and the critical need to build trust early in the research process. [6] [7] [8] Much of the literature to date has focused on stakeholder engagement in specific tasks such as the development of research agendas [9] [10] [11] [12] [13] or on the involvement of patients and other stakeholders across the phases of discreet CER and PCOR studies. [14] [15] [16] [17] However, effectively engaging stakeholders in the development and oversight of research infrastructure, as required for PCORnet, brings both distinct challenges and corresponding opportunities. In this paper, we describe the pro- that ensure strict adherence to standards of data security, patient privacy, and research ethics. Although PCORI required that networks applying to participate in PCORnet demonstrate a robust plan for engaging patients and other stakeholders consistent with the PCORI engagement rubric, 18 they intentionally avoided proscribing specific engagement methods, thus allowing each network to design an engagement strategy to fit their unique characteristics and needs.
CDRNs have employed a range of frameworks and methods to engage patients and other healthcare stakeholders (e.g., clinicians and health system leaders) in network-level governance as well as study- focus, including a PCOR advocate/PCORI ambassador, a community health charities director, a regional health officer for the Illinois Department of Public Health, and a retired pastor with a long history of community advocacy. Sixty-five percent of PCAC members were female. The group included one Hispanic member and was otherwise evenly split between white and black participants. We did not ask members their age, but all were over the age of 30 with the majority in the 40-60 age range.
| Compensation
All members of the PCAC were provided the same level of compensation for participating in quarterly meetings and were reimbursed for expenses related to meeting attendance (ie, transportation and parking). Members who took on network roles beyond the PCAC received additional compensation.
| Member orientation
A number of steps were taken to orient PCAC members to These meetings also provided an opportunity for PCAC members to get to know each other as individuals. Given the inclusion of patients and clinicians in the same group, we were cognizant of the potential for perceived power differentials to interfere with group dynamics.
Therefore, we introduced procedures aimed at counteracting this tendency such as referring to all members by their first name, engaging clinician/patient dyads in one-on-one conversations, and ensuring that everyone had an equal opportunity to contribute to group discussions.
| Roles and functions
The PCAC was envisioned as the central hub of patient and clinician engagement within CAPriCORN. In addition to working as a group to develop policies and address challenges as the CDRN developed, PCAC members would be designated to serve as members of the CAPriCORN steering committee, join standing working groups, and participate in ad hoc committees related to specific research projects or issues. Importantly, PCAC members were also intended to serve as liaisons to the broader stakeholder communities they represent, facilitating the transfer of information from and back to the larger community. To facilitate patient and clinician participation throughout the research process, core functions of the PCAC included research prioritization, protocol review, and dissemination of study results. 
| Complexity of network development
Although perhaps overused, the metaphor of "building a plane while A related challenge involved maintaining group members' interest and commitment when the timeline for seeing tangible benefits may extend far into the future. Actively engaging stakeholders over the course of a multiyear research study is itself a difficult task. The challenge is compounded when a significant time period is required for the network to become "research ready." Finding ways to demonstrate that progress is being made and help stakeholders remain committed to the ultimate network goals is critical to sustaining engagement.
| PCAC breadth versus depth
The size and composition of the PCAC created additional challenges. 
| Research process and timelines
Other challenges were associated with the process for integrating PCAC input into research initiated or supported by CAPriCORN. A critical early task for the network was determining how requests to use CAPriCORN data, or otherwise collaborate with the CDRN, would be vetted and approved by the appropriate groups and committees.
PCAC initiated a process flow diagram to show how community voices could be integrated into the research process and to help visualize the CAPriCORN/PCORnet imperative of maintaining patient centeredness while respecting the overall goal of creating infrastructure and processes to facilitate research. The resulting plan required that PCAC review any request that involved identifiable patient data or contact with CAPriCORN patients or clinicians. In addition, the PCAC would only be asked to review requests for which a full proposal or study protocol was available (ie, requests for preliminary, nonbinding letters of support were not reviewed by the PCAC).
With the role of the PCAC in the overall review and approval process defined, the group set out to determine the process and criteria that would be used for PCAC reviews. Patient and stakeholder partners in individual research studies typically have direct experience with the disease or condition in question and are therefore able to provide very specific input regarding appropriate research questions, procedures, and outcomes. Because the PCAC would need to consider research related to any given disease area, the review criteria needed to be broadly applicable and not require experience or expertise relevant to a specific condition.
During an early in-person meeting, the PCAC developed a list of study outcome domains that they considered high priority. These included outcomes that, although important to members of the PCAC,
are not typically included in research protocols. For example, the group felt strongly that outcomes related to caregiver burden should be more frequently considered. The resulting list of desirable outcome domains became one component of the PCAC review criteria.
Although requests were not discounted for failure to include certain outcomes, feedback to investigators included suggestions for relevant outcomes that could strengthen the patient-centeredness of their research. The full set of review criteria is included in Table 1 .
With regard to the process for PCAC reviews, it was critical to consider the rapid timelines often associated with research-related requests. A small group of PCAC members convened to finalize the review criteria and forms, test them out by reviewing several protocols as a group, and develop a plan for training additional PCAC members to serve as reviewers. Despite this preparation, it has proven difficult to integrate PCAC review into the overall network review and approval process. A clinician representative on the PCAC described it this way "The workflow did not permit PCAC to provide researchers with feedback on their study design early enough in the process. As a result, the potential benefit to the community and researchers was not fully realized."
This has been partly because of the lack of a robust pipeline of proposals requiring PCAC review and therefore a lack of training opportunities, as the CDRN worked toward becoming fully operational. The variety of ways in which requests were coming into the network also contributed to the challenge. The recent opening of CAPriCORN's "Front Door" (a centralized portal for all researchrelated requests) should lead to an increased proposal pipeline and also help to streamline the overall process, including review by the PCAC when required.
| FUTURE DIRECTION
As the conclusion of the PCORI funding period approaches, and CAPriCORN looks toward a streamlined and sustainable path forward, the PCAC leadership team closely examined the lessons learned about patient and clinician engagement in CAPriCORN along with the evolving needs of the network. With input from the PCAC membership, a plan was developed that seeks to ensure that the network maintains its focus on the needs of patients and the community, while maximizing the use of available resources.
The transition was marked by changing the name of the group from the patient and clinician advisory committee to the patient and community advisory committee. This was not intended to minimize the importance of clinician views but rather to elevate and empower patient and community leadership of the group. The group will maintain a balance of two patient/community representatives to everyone health professional, with a total group size of eight to ten individuals.
Whereas the PCAC was previously cochaired by clinicians from two participating institutions with expertise in community engagement, the group is now led by two community representatives with support from patient and clinician mentors. A patient representative on the PCAC described the transition this way:
"Most notable to me is the rising up, and assertion, of leadership among the non-clinician members. I am inspired by the commitment, vision, and determination of our new co-chairs, bringing a heightened sense of purpose, duty, and opportunity to the group."
Rather than including individuals with interests specific to particular disease areas, the PCAC is now composed of community members and health professionals interested in advocating for the patient perspective in health care research. An emphasis was placed on including individuals who can serve as liaisons to the broader stakeholder communities they represent. In this respect, the current composition is more aligned with frameworks for community engagement as opposed to patient engagement. 21 
| CONCLUSIONS
The experiences of the CAPriCORN PCAC to date highlight some key challenges and potential solutions that may be informative for others attempting to engage patients and other stakeholders in creating a sustainable, patient-centered research network. First, network formation is a complex and dynamic process, and stakeholders may struggle to grasp and maintain commitment to potential outcomes that may take years to fully materialize. Multiple strategies are needed to convey the ultimate goal of improving health outcomes and to demonstrate progress toward that goal. Second, it can be challenging to determine the appropriate advisory group composition for a broadly focused, multisystem network such as CAPriCORN. A large, diverse group offered some early advantages in terms of representation of multiple viewpoints. However, we found that a smaller, more actively engaged group with connections to the broader community made more sense once the network was fully functional. Whether for a multisystem network or a single institution, careful consideration should be given to the role and responsibilities of the advisory group and the population it is intended to represent. Finally, incorporating patient and community input into the research review process can be complicated by short timelines, requests from diverse sources, and multiple levels of review and approval. Involving all network stakeholders in developing a review process that recognizes the importance of the patient/community perspective and enables meaningful participation is critical.
